Naloxone Viatris (Anhydrous Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxone Viatris, is an opioid antagonist presented as an injectable solution for intravenous use. It rapidly reverses opioid‑induced respiratory depression and is employed in emergency treatment of opioid overdose in adults and children.

GNH USA supplies Naloxone Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naloxone is an opioid antagonist used in the management of acute opioid toxicity and related respiratory compromise. - Opioid overdose: rapidly restores adequate breathing and consciousness in patients with life‑threatening opioid intoxication. - Opioid‑induced respiratory depression: reverses depressed ventilation caused by therapeutic or illicit opioid use. - Opioid toxicity in emergency settings: provides immediate antagonism to prevent fatal outcomes during pre‑hospital or hospital resuscitation.

Naloxone is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate feeling of stomach upset. - Sweating: increased perspiration often accompanying withdrawal. - Tachycardia: rapid heart rate after antagonism. - Agitation or anxiety: nervousness during reversal of opioid effects.

Serious or Rare Side Effects: - Severe hypertension: sudden high blood pressure requiring monitoring. - Cardiac arrhythmias: irregular heart rhythms that may need intervention. - Pulmonary edema: fluid accumulation in the lungs, a medical emergency. - Anaphylaxis: rare allergic reaction with airway compromise.

Naloxone should be used with careful clinical assessment and monitoring. - Assess opioid dependence: anticipate possible acute withdrawal symptoms. - Monitor respiratory status: observe for recurrent depression after initial reversal. - Check for hypersensitivity: avoid administration if known allergy to naloxone. - Use cautiously in cardiovascular disease: may cause transient hypertension. - Pregnancy and lactation: limited data; weigh benefits against potential risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Naloxone may interact with other agents that affect opioid pathways or cardiovascular function.

Major Interactions (Avoid): - Concomitant opioid antagonists: may precipitate severe withdrawal. - Chronic high‑dose opioid therapy: can diminish analgesic effect and provoke withdrawal.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia induced by naloxone. - Monoamine oxidase inhibitors: theoretical risk of hypertensive response. - Sedatives or CNS depressants: additive central effects requiring observation.